약학회지

ISSN 0377-9556 (PRINT)
ISSN 2383-9457 (ONLINE)
Table. 2. Status of e-labels in countries (South Korea, Japan, Singapore, European Union)
South Korea Japan Singapore Europe Union
Legal basis Yes (Pilot) Yes No (Pilot) No (Pilot)
Target Prescription Medicines Prescription Medicines All Medicines (Prescription/Non-prescription) All Medicines (Prescription/Non-prescription)
Package leaflet type Package Leaflets (target audience not considered) Package Leaflets for Healthcare Professionals Package Inserts (for HCP*) and Patient Information Leaflets (for patients & consumers) Summary of Product Characteristics (SmPC) (for HCP*) and Package Leaflets (for patients & consumers)
Distribution method E-label Only (Paper Inserts Provided upon Request) E-label Only (Paper Inserts Provided upon Requests and Certain Conditions) E-label Only E-label & Paper Package Leaflets
Replacing Paper Inserts Possible Possible Possible Impossible
E-label developing entity Marketing Authorization Holder Marketing Authorization Holder Marketing Authorization Holder Marketing Authorization Holder
Distribution Platform Marketing Authorization Holder website PMDA website Marketing Authorization Holder website EMA website (Product Lifecycle Management Portal)

*Note: The United States is excluded from this table because although there have been past discussions about adopting e-labels, no concrete action has been taken.

*HCP: Healthcare Professionals

Yakhak Hoeji 2024;68:239-51 https://doi.org/10.17480/psk.2024.68.4.239
© 2024 Yakhak Hoeji